Ashizawa T - Search Results

1

SCA8 RAN polySer protein preferentially accumulates in white matter regions and is regulated by eIF3F.

Ayhan F, Perez BA, Shorrock HK, Zu T, Banez-Coronel M, Reid T, Furuya H, Clark HB, Troncoso JC, Ross CA, Subramony SH, Ashizawa T, Wang ET, Yachnis AT, Ranum LP. Ayhan F, et al. Among authors: ashizawa t. EMBO J. 2018 Oct 1;37(19):e99023. doi: 10.15252/embj.201899023. Epub 2018 Sep 11. EMBO J. 2018. PMID: 30206144 Free PMC article.

2

Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel.

Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Zhuchenko O, et al. Among authors: ashizawa t. Nat Genet. 1997 Jan;15(1):62-9. doi: 10.1038/ng0197-62. Nat Genet. 1997. PMID: 8988170

3

What is Kearns-Sayre syndrome after all?

Ashizawa T, Subramony SH. Ashizawa T, et al. Arch Neurol. 2001 Jul;58(7):1053-4. doi: 10.1001/archneur.58.7.1053. Arch Neurol. 2001. PMID: 11448292 No abstract available.

4

Spinocerebellar ataxia type 10 is rare in populations other than Mexicans.

Matsuura T, Ranum LP, Volpini V, Pandolfo M, Sasaki H, Tashiro K, Watase K, Zoghbi HY, Ashizawa T. Matsuura T, et al. Among authors: ashizawa t. Neurology. 2002 Mar 26;58(6):983-4. doi: 10.1212/wnl.58.6.983. Neurology. 2002. PMID: 11914424 No abstract available.

5

Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia.

Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, Seltzer WK, Pandolfo M, Milunsky A, Potter NT, Shoji M, Vincent JB, Day JW, Ranum LP. Ikeda Y, et al. Among authors: ashizawa t. Am J Hum Genet. 2004 Jul;75(1):3-16. doi: 10.1086/422014. Epub 2004 May 19. Am J Hum Genet. 2004. PMID: 15152344 Free PMC article.

6

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

Subramony SH, May W, Lynch D, Gomez C, Fischbeck K, Hallett M, Taylor P, Wilson R, Ashizawa T; Cooperative Ataxia Group. Subramony SH, et al. Among authors: ashizawa t. Neurology. 2005 Apr 12;64(7):1261-2. doi: 10.1212/01.WNL.0000156802.15466.79. Neurology. 2005. PMID: 15824358

7

Measuring Friedreich ataxia: complementary features of examination and performance measures.

Lynch DR, Farmer JM, Tsou AY, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Wilson RB, Balcer LJ. Lynch DR, et al. Among authors: ashizawa t. Neurology. 2006 Jun 13;66(11):1711-6. doi: 10.1212/01.wnl.0000218155.46739.90. Neurology. 2006. PMID: 16769945 Clinical Trial.

8

Antioxidant use in Friedreich ataxia.

Myers L, Farmer JM, Wilson RB, Friedman L, Tsou A, Perlman SL, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews KD, Balcer LJ, Lynch DR. Myers L, et al. Among authors: ashizawa t. J Neurol Sci. 2008 Apr 15;267(1-2):174-6. doi: 10.1016/j.jns.2007.10.008. Epub 2007 Nov 7. J Neurol Sci. 2008. PMID: 17988688 Free PMC article. Clinical Trial.

9

Health related quality of life measures in Friedreich Ataxia.

Epstein E, Farmer JM, Tsou A, Perlman S, Subramony SH, Gomez CM, Ashizawa T, Wilmot GR, Mathews K, Wilson RB, Balcer LJ, Lynch DR. Epstein E, et al. Among authors: ashizawa t. J Neurol Sci. 2008 Sep 15;272(1-2):123-8. doi: 10.1016/j.jns.2008.05.009. Epub 2008 Jun 20. J Neurol Sci. 2008. PMID: 18571673

10

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design.

Friedman LS, Farmer JM, Perlman S, Wilmot G, Gomez CM, Bushara KO, Mathews KD, Subramony SH, Ashizawa T, Balcer LJ, Wilson RB, Lynch DR. Friedman LS, et al. Among authors: ashizawa t. Mov Disord. 2010 Mar 15;25(4):426-32. doi: 10.1002/mds.22912. Mov Disord. 2010. PMID: 20063431 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

480 results

Search Page